Trending Articles

article thumbnail

STAT+: 23andMe’s bankruptcy is the worst thing that could happen to just about everyone involved

STAT

How did 23andMe go bankrupt? The same way bankruptcy was described by Ernest Hemingway in 1926: “Two ways: Gradually, and then suddenly.” Since its founding in 2006, the company, which aimed to give consumers access to their genetic information, faced what seemed like one killing blow after another: questions of whether its business was ethical, the Food and Drug Administration blocking the sale of its tests, and, last year, a cyberattack in which hackers gained access to the recor

360
360
article thumbnail

Brexit a key factor in worst UK medicine shortages in four years, report says

The Guardian - Pharmaceutical Industry

Nuffield Trust says supply chains have shifted, with drugs for epilepsy and cystic fibrosis among those now scarce Drug shortages in the UK have risen to their worst level for four years, official figures show, with Brexit considered a key reason so many medications are scarce. Drug companies notified the Department of Health and Social Care (DHSC) about disruptions to supply 1,938 times during last year the highest number since the 1,967 seen in 2021.

112
112
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Former CDC director Tom Frieden shares warning for RFK Jr. on measles outbreak

STAT

NEW YORK —   A former top federal health official is publicly warning Robert F. Kennedy Jr. that wavering on vaccines and slashing federal programs during a deadly measles outbreak could unleash the next public health disaster.  “The federal government might pause, but the measles virus doesn’t pause. Bacteria and viruses don’t pause.

Vaccines 363
article thumbnail

Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes

Express Pharma

Eli Lilly and Company (India) announced the launch of Mounjaro in single-dose vial presentation following the marketing authorisation from the Central Drugs Standard Control Organization (CDSCO). It is a treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.

Diabetes 101
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Psilocybin therapy demonstrates sustained clinical benefit in treatment-resistant depression

European Pharmaceutical Review

New results from a trial investigating a synthetic form of psilocybin, administered with psychological support, showed that it extended the time participants with treatment-resistant depression (TRD) were free from depressive symptoms. A single 25mg dose of COMP360 psilocybin had benefit over smaller 1mg and 10mg doses in the 52-week COMP004 follow-up study to the Phase IIb (COMP001 and COMP003) trials.

98

More Trending

article thumbnail

Opinion: How to protect the American egg supply from avian flu  

STAT

Wholesale egg prices have dropped by more than 40% since late February, a decline that should soon translate into broader savings for consumers at grocery stores. This welcome respite has largely resulted from the lull in significant bird flu outbreaks in recent weeks, perhaps due to seasonal patterns in the virus’s transmission. North American flyways typically remain quiet in February as migratory birds have yet to start their journeys from their winter habitats.

article thumbnail

Drug Patent Expirations: Unlocking Strategic Investment Opportunities

Drug Patent Watch

Unlocking Strategic Investment Opportunities in the Pharmaceutical Industry As we navigate the ever-evolving landscape of the pharmaceutical industry, one thing remains constant: the expiration of patents on blockbuster medications. These expirations can have a significant impact on the market, creating opportunities for strategic investment and growth.

article thumbnail

FOPE & PharmaState Academy conducts session 17 on gap analysis and implementation plan for Revised Schedule M

Express Pharma

The Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy successfully conducted Session 17 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative, delivering comprehensive guidance on gap analysis and implementation plan for revised Schedule M compliance. The 3.5-hour workshop provided participants with direction, supplementary documentation, and hands-on learning, ensuring they were well-equipped to meet compliance requirements.

article thumbnail

The End of the Blockbuster Era: Unlocking Growth with Direct-to-Patient Commercialization

Drug Channels

Todays guest post comes from Greg Skalicky, President of EVERSANA. Greg discusses some of the challenges manufacturers face with product commercialization, patient access and adherence, and negotiating partnerships with pharmacy benefit managers (PBMs). He introduces us to EVERSANA DIRECT Commercialization, a direct-to-patient change/model. To learn more about EVERSANA DIRECT Commercialization and how the direct-to-patient model can help you, meet with EVERSANA at the Asembia Summit in Las Vegas

98
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

The industry heavyweight behind Novavax’s push to bounce back

PharmaVoice

As it returns from the brink, the vaccine developer has brought in Dr. Ruxandra Draghia-Akli — and her industry and public health chops — to lead R&D.

Vaccines 221
article thumbnail

‘We’ve vanished’: U.S. aid cuts leave health workers around the world reeling

STAT

For eight years, Ntombi, who worked at a health organization in Johannesburg, helped caregivers tell their HIV-positive children about the disease they had. She made sure those children stayed on the medications that suppressed the virus. She visited her patients at their homes to get them any food and financial support they needed.  But then, one day in late January, she was told she had to stop her work, immediately.

363
363
article thumbnail

Why Healthcare is Seeing an Increase in 2025 Ad Budgeting

Pharma Marketing Network

Introduction The healthcare industry is undergoing a significant transformation, and ad budgeting is at the center of this shift. With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025.

article thumbnail

Tech Mahindra, NVIDIA collaborate to advance drug safety with agentic AI-powered pharmacovigilance solution

Express Pharma

Tech Mahindra announced a pharmacovigilance (PV) autonomous solution built with NVIDIA AI software to advance drug safety management. The solution leverages agentic artificial intelligence (AI) and automation to enhance the accuracy, speed, and efficiency of pharmacovigilance processes, addressing critical industry challenges such as manual delays and data overload.

71
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing

The Guardian - Pharmaceutical Industry

Pharmaceutical company will invest money over five years in strategic partnership with the citys authorities Business live latest updates AstraZeneca will invest $2.5bn in research and manufacturing in Beijing, as the pharmaceutical company tries to move past recent controversies including ditching plans for the expansion of a UK vaccine plant and the detentions of top executives in China.

article thumbnail

The key factors shaping China’s biopharma boom

PharmaVoice

Chinese companies are involved in one-fifth of pharma’s clinical development programs, but trade wars and regulatory hurdles could stymie dealmaking.

147
147
article thumbnail

Which Social Media Analytics Matter Most in Pharma Marketing

Pharma Marketing Network

Introduction Social media has become an essential tool for pharmaceutical marketing. However, simply posting content is not enough. To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. But which metrics truly matter? With increasing regulations, evolving digital trends, and shifting audience behaviors, pharma marketers need to analyze data that aligns with brand goals, compliance requirements, and engagement strategies.

HIPAA 52
article thumbnail

Sovereign Pharma gains EU approval for aseptic and terminally sterilised injectable products

Express Pharma

Sovereign Pharma, gains EU approval for aseptic and terminally sterilised products, including vials, ampoules, cartridges, and pre-filled syringes (PFS) for both liquid and lyophilized formulations. This achievement is a significant step in the companys commitment to quality, safety, and global healthcare excellence. In addition to the EU approval, ANVISA, the regulatory body under Brazils Ministry of Health, granted approval for aseptically processed and terminally sterilised small volume paren

85
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Hopes pharmacy contract will include NI uplift after 'disappointing' MPs vote

The Pharmacist

Pharmacy leaders have expressed hope that the long awaited pharmacy contract will include an uplift to cover increased National Insurance Contributions (NICs), after MPs voted yesterday against exempting pharmacy employers from the measure. Last month, peers in the House of Lords voted to freeze NICs for primary care employersat 13.8%. This would have seen them […] The post Hopes pharmacy contract will include NI uplift after 'disappointing' MPs vote appeared first on The Pharmac

59
article thumbnail

Rx-to-OTC rule gets pushed back — again

PharmaVoice

A delay of the prescription-to-OTC rule signals health agencies’ ongoing reluctance to implement new regulations.

130
130
article thumbnail

STAT+: 23andMe files for bankruptcy as CEO Anne Wojcicki resigns

STAT

23andMe said late Sunday it will file for bankruptcy and CEO and co-founder Anne Wojcicki will depart, after she repeatedly tried and failed to take the storied but financially troubled DNA-testing startup private.  The company will now try to sell itself through a court-supervised sale. It closed Friday valued at a hair under $50 million, a calamitous fall from 2021, when it went public and soared to a nearly $6 billion market cap.

348
348
article thumbnail

Audience Engagement Strategies for Pharma Marketing: Boost HCP and Patient Interaction

Pharma Marketing Network

Introduction In the highly regulated pharmaceutical industry, audience engagement is more than just a marketing goalit is a necessity for building trust with healthcare professionals (HCPs) and patients. But how can pharma brands create meaningful connections in a digital landscape crowded with content? Unlike traditional consumer marketing, pharma marketing requires a strategic approach that balances compliance, education, and innovation.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

NHS approval of endometriosis therapy Ryeqo enhances patient care: GlobalData

Express Pharma

The National Health Service (NHS) in England has approved Gedeon Richters Ryeqo, the first long-term pill available for endometriosis for patients who have exhausted all other treatment options. The approval addresses the long-standing gap in long-term treatment options for endometriosis, improving overall disease management while easing the burden on healthcare resources, says GlobalData.

Dosage 66
article thumbnail

Strategies for effective biosimilar regulatory agency interactions

Drug Patent Watch

Navigating the Complex World of Biosimilar Regulatory Agency Interactions As a biosimilar developer, you know that getting your product to market can be a long and arduous process. One of the most critical components of this journey is interacting with regulatory agencies. But how can you ensure that these interactions are effective and set your product up for success?

article thumbnail

Biogen plots new global headquarters in Kendall Square

PharmaVoice

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.

130
130
article thumbnail

STAT+: Gene therapies and CRISPR drugs slowed by ‘irrational pessimism,’ say scientists forging new paths

STAT

NEW YORK — To gene therapy pioneer Jim Wilson, the field is currently clouded with “irrational pessimism.” Companies are abandoning ship; approved therapies aren’t being prescribed. Yet both he and University of Pennsylvania researcher Kiran Musunuru are forging ahead, using contrasting approaches, as they explained onstage at STAT’s Breakthrough Summit East.

282
282
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.